Insider Transactions in Q4 2021 at Clovis Oncology, Inc. (CLVS)
Insider Transaction List (Q4 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 02
2021
|
Paul Edward Gross Officer |
SELL
Open market or private sale
|
Direct |
248
-0.4%
|
$744
$3.0 P/Share
|
|
Dec 02
2021
|
Gillian C Ivers Read Officer |
SELL
Open market or private sale
|
Direct |
304
-0.12%
|
$912
$3.0 P/Share
|
|
Dec 02
2021
|
Thomas C. Harding Officer |
SELL
Open market or private sale
|
Indirect |
7
-0.45%
|
$21
$3.0 P/Share
|
|
Dec 02
2021
|
Thomas C. Harding Officer |
SELL
Open market or private sale
|
Direct |
141
-2.55%
|
$423
$3.0 P/Share
|
|
Dec 02
2021
|
Daniel W Muehl Officer |
SELL
Open market or private sale
|
Direct |
248
-0.37%
|
$744
$3.0 P/Share
|
|
Dec 02
2021
|
Lindsey Rolfe Officer |
SELL
Open market or private sale
|
Direct |
346
-0.42%
|
$1,038
$3.0 P/Share
|
|
Dec 01
2021
|
Paul Edward Gross Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
562
+0.9%
|
-
|
|
Dec 01
2021
|
Gillian C Ivers Read Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
687
+0.26%
|
-
|
|
Dec 01
2021
|
Thomas C. Harding Officer |
BUY
Exercise of conversion of derivative security
|
Indirect |
18
+1.15%
|
-
|
|
Dec 01
2021
|
Thomas C. Harding Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
281
+4.83%
|
-
|
|
Dec 01
2021
|
Daniel W Muehl Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
562
+0.82%
|
-
|
|
Dec 01
2021
|
Lindsey Rolfe Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
687
+0.82%
|
-
|
|
Nov 02
2021
|
Thomas C. Harding Officer |
SELL
Open market or private sale
|
Indirect |
62
-3.89%
|
$248
$4.55 P/Share
|
|
Nov 02
2021
|
Thomas C. Harding Officer |
SELL
Open market or private sale
|
Direct |
1,682
-14.93%
|
$6,728
$4.55 P/Share
|
|
Nov 02
2021
|
Daniel W Muehl Officer |
SELL
Open market or private sale
|
Direct |
4,523
-3.33%
|
$18,092
$4.55 P/Share
|
|
Nov 02
2021
|
Paul Edward Gross Officer |
SELL
Open market or private sale
|
Direct |
4,523
-3.65%
|
$18,092
$4.55 P/Share
|
|
Nov 02
2021
|
Lindsey Rolfe Officer |
SELL
Open market or private sale
|
Direct |
4,209
-2.52%
|
$16,836
$4.55 P/Share
|
|
Nov 02
2021
|
Gillian C Ivers Read Officer |
SELL
Open market or private sale
|
Direct |
3,696
-0.71%
|
$14,784
$4.55 P/Share
|
|
Nov 01
2021
|
Thomas C. Harding Officer |
BUY
Exercise of conversion of derivative security
|
Indirect |
181
+10.2%
|
-
|
|
Nov 01
2021
|
Thomas C. Harding Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,374
+23.05%
|
-
|
|
Nov 01
2021
|
Daniel W Muehl Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,248
+7.01%
|
-
|
|
Nov 01
2021
|
Paul Edward Gross Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,248
+7.64%
|
-
|
|
Nov 01
2021
|
Lindsey Rolfe Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,374
+4.78%
|
-
|
|
Nov 01
2021
|
Gillian C Ivers Read Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,374
+1.58%
|
-
|
|
Oct 04
2021
|
Thomas C. Harding Officer |
SELL
Open market or private sale
|
Indirect |
6
-0.42%
|
$24
$4.41 P/Share
|
|
Oct 01
2021
|
Thomas C. Harding Officer |
BUY
Exercise of conversion of derivative security
|
Indirect |
15
+1.05%
|
-
|